Journal article · 2022 · Open access

HPR34 Emerging Role of Patient Reported Outcomes in Drug Approval in Europe

S Pal, RV Magimaidas, S Sreedharan, Subhashis Ghosh, M Chatterjee

Value in Health, 25(12), S238 · Published 1 December 2022 · DOI 10.1016/j.jval.2022.09.1166

Open full textCite this paper

In brief

“HPR34 Emerging Role of Patient Reported Outcomes in Drug Approval in Europe” is a 2022 journal article by S Pal and 4 co-authors, published in Value in Health. OpenAlex counts 0 citations as of 22 November 2026. It is open access: the full text is free to read at Value in Health.

Citations
0
Authors
5

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Pal, S., Magimaidas, R., Sreedharan, S., Ghosh, S., & Chatterjee, M. (2022). HPR34 Emerging Role of Patient Reported Outcomes in Drug Approval in Europe. Value in Health, 25(12), S238. https://doi.org/10.1016/j.jval.2022.09.1166

MLA 9

Pal, S, et al. “HPR34 Emerging Role of Patient Reported Outcomes in Drug Approval in Europe.” Value in Health, vol. 25, no. 12, 2022, p. S238. https://doi.org/10.1016/j.jval.2022.09.1166.

Chicago

Pal, S, RV Magimaidas, S Sreedharan, Subhashis Ghosh, and M Chatterjee. 2022. “HPR34 Emerging Role of Patient Reported Outcomes in Drug Approval in Europe.” Value in Health 25 (12): S238. https://doi.org/10.1016/j.jval.2022.09.1166.

Harvard

Pal, S. et al. (2022) ‘HPR34 Emerging Role of Patient Reported Outcomes in Drug Approval in Europe’, Value in Health, 25(12), p. S238. doi:10.1016/j.jval.2022.09.1166.

IEEE

S. Pal, R. Magimaidas, S. Sreedharan, S. Ghosh, and M. Chatterjee, “HPR34 Emerging Role of Patient Reported Outcomes in Drug Approval in Europe,” Value in Health, vol. 25, no. 12, p. S238, 2022, doi: 10.1016/j.jval.2022.09.1166.

BibTeX

@article{pal2022emerging,
  title     = {{HPR34 Emerging Role of Patient Reported Outcomes in Drug Approval in Europe}},
  author    = {Pal, S and Magimaidas, RV and Sreedharan, S and Ghosh, Subhashis and Chatterjee, M},
  journal   = {Value in Health},
  year      = {2022},
  volume    = {25},
  number    = {12},
  pages     = {S238},
  doi       = {10.1016/j.jval.2022.09.1166},
  url       = {https://doi.org/10.1016/j.jval.2022.09.1166}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life

  • patient-reported outcomes
  • drug approval
  • European Medicines Agency
  • regulatory decision-making
  • digital health technologies
  • patient perspectives
  • clinical trial endpoints

Work with this paper

Most-cited papers in Economics, Econometrics and Finance

All highly cited Economics, Econometrics and Finance papers

Questions about this paper

How do I cite this paper in APA style?

Pal, S., Magimaidas, R., Sreedharan, S., Ghosh, S., & Chatterjee, M. (2022). HPR34 Emerging Role of Patient Reported Outcomes in Drug Approval in Europe. Value in Health, 25(12), S238. https://doi.org/10.1016/j.jval.2022.09.1166

How many times has this paper been cited?

0 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Value in Health: sign in and open the full text from this page.

Who wrote this paper?

S Pal, RV Magimaidas, S Sreedharan, Subhashis Ghosh, M Chatterjee.

What is the DOI of this paper?

10.1016/j.jval.2022.09.1166, permanently at https://doi.org/10.1016/j.jval.2022.09.1166. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.